Mental health patient-reported outcomes among adolescents and young adult cancer survivors: A systematic review.
adolescent
cancer
cancer survivors
mental health
patient-reported outcome measures
routinely collected health data
young adult
Journal
Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
revised:
27
07
2023
received:
08
03
2023
accepted:
02
08
2023
medline:
4
10
2023
pubmed:
19
8
2023
entrez:
19
8
2023
Statut:
ppublish
Résumé
Adolescent and young adult (AYA) cancer patients and survivors face significant mental health challenges throughout their cancer journey that are different to those faced by children and older adults. Patient-reported outcome measures (PROMs) can be used to explore the experiences of AYAs, and to identify important issues and areas for potential improvement in quality of life. We aimed to compare patient reported mental health outcomes between AYAs diagnosed with cancer and non-cancer controls. We built on a larger systematic review of AYA cancer PROMs which searched PubMed, EMBASE, CINAHL and PsychINFO. This review identified 175 articles, which were filtered to those reporting on mental health and including a non-cancer control group. We identified 12 eligible studies. Seven studies (58%) found those diagnosed with cancer reported poorer mental health than the non-cancer controls. The remaining five (42%) studies found no significant difference in severity or prevalence of mental health between the AYA cancer cohort and the healthy control group. Most (83%) were cross-sectional studies, highlighting the need for further longitudinal assessment of this group throughout their journey. The mental health outcomes feature conflicting results and illustrate the need for larger studies to characterise discrepancies.
Sections du résumé
BACKGROUND
Adolescent and young adult (AYA) cancer patients and survivors face significant mental health challenges throughout their cancer journey that are different to those faced by children and older adults. Patient-reported outcome measures (PROMs) can be used to explore the experiences of AYAs, and to identify important issues and areas for potential improvement in quality of life.
OBJECTIVE
We aimed to compare patient reported mental health outcomes between AYAs diagnosed with cancer and non-cancer controls.
METHOD
We built on a larger systematic review of AYA cancer PROMs which searched PubMed, EMBASE, CINAHL and PsychINFO. This review identified 175 articles, which were filtered to those reporting on mental health and including a non-cancer control group.
RESULTS
We identified 12 eligible studies. Seven studies (58%) found those diagnosed with cancer reported poorer mental health than the non-cancer controls. The remaining five (42%) studies found no significant difference in severity or prevalence of mental health between the AYA cancer cohort and the healthy control group. Most (83%) were cross-sectional studies, highlighting the need for further longitudinal assessment of this group throughout their journey.
CONCLUSIONS
The mental health outcomes feature conflicting results and illustrate the need for larger studies to characterise discrepancies.
Identifiants
pubmed: 37596768
doi: 10.1002/cam4.6444
pmc: PMC10524059
doi:
Types de publication
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
18381-18393Informations de copyright
© 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Références
Psychooncology. 2019 Mar;28(3):577-585
pubmed: 30636177
Health Serv Insights. 2013 Aug 04;6:61-8
pubmed: 25114561
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Cancer. 2012 Oct 1;118(19):4884-91
pubmed: 22688896
J Adolesc Young Adult Oncol. 2014 Jun 1;3(2):66-74
pubmed: 24940530
J Adolesc Young Adult Oncol. 2021 Dec;10(6):629-644
pubmed: 33306001
Support Care Cancer. 2018 Sep;26(9):3099-3110
pubmed: 29572734
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Breast Cancer. 2020 Nov;27(6):1177-1186
pubmed: 32583350
Cancer. 2021 Apr 15;127(8):1325-1333
pubmed: 33332603
J Cancer Surviv. 2016 Apr;10(2):280-90
pubmed: 26248766
Cancer. 2016 Apr 1;122(7):1009-16
pubmed: 26848927
Psychooncology. 2014 Feb;23(2):121-30
pubmed: 24105788
Psychooncology. 2022 Sep;31(9):1448-1458
pubmed: 35734846
J Clin Epidemiol. 1999 May;52(5):405-12
pubmed: 10360335
CA Cancer J Clin. 2020 Nov;70(6):443-459
pubmed: 32940362
J Clin Oncol. 2021 Mar 20;39(9):1010-1019
pubmed: 33492982
Crit Rev Oncol Hematol. 2023 Jan;181:103867
pubmed: 36427770
Cancer. 2022 Apr 1;128(7):1523-1531
pubmed: 35001391
Psychooncology. 2018 May;27(5):1404-1411
pubmed: 28672093
Cancer Med. 2023 Sep;12(17):18381-18393
pubmed: 37596768
Qual Life Res. 2014 May;23(4):1377-86
pubmed: 24197479
Ann Oncol. 2013 Apr;24(4):895-900
pubmed: 23175625
J Cancer Surviv. 2021 Aug;15(4):564-575
pubmed: 33089480
Lancet Oncol. 2022 Apr;23(4):e184-e196
pubmed: 35358467
Cancers (Basel). 2021 Sep 28;13(19):
pubmed: 34638332
J Clin Oncol. 2017 Feb 20;35(6):652-659
pubmed: 28095151
J Clin Oncol. 2013 Jun 10;31(17):2160-6
pubmed: 23650425
Cancer. 2014 Aug 1;120(15):2247-54
pubmed: 24888335
Campbell Syst Rev. 2022 Mar 27;18(2):e1230
pubmed: 36911350
Arch Psychiatr Nurs. 2013 Dec;27(6):299-305
pubmed: 24238010
J Clin Oncol. 2013 Jun 10;31(17):2136-45
pubmed: 23650427